Company

About

Anogen-Yes Biotech Laboratories

Anogen-Yes Biotech Laboratories

Mississauga, Ontario, Canada

Anogen-Yes Biotech Laboratories Ltd. is a biotech company located in Mississauga, Canada. Founded in 1989, we have been a proud supplier of high quality antibody-based products for 30 years. We offer more than 300 monoclonal and polyclonal antibodies and more than 60 types of ELISA kits for research, diagnostic and therapeutic applications. As a research-focused company, we have also developed many a number of proprietary diagnostic and therapeutic products. Our product Abcream, an effective anti-IL-8 (CXCL8) monoclonal antibody topical treatment for psoriasis, had received approval by State Food & Drug Administration (SFDA) of China in 2001 and many international patents. Our neonatal TSH ELISA kit for diagnostic purposes has also been licensed by Health Canada. We also initiated research and developed products for inflammation, Alzheimer’s disease, and cancer. Learn more about our R&D projects under the “R&D Projects” tab. We have been ISO certified since 2000. We guarantee that every product delivered to our customers is of the best quality. With our in-house cell bank of more than 1000 hybridomas, we are able to monitor and control the entire manufacturing progress to ensure that our antibodies and ELISA kits are the best on the market. We provide antibodies, ELISA kits, and other lab reagents to major biotechnology and pharmaceutical companies, laboratories, hospitals, and academic and government research institutions around the world. We also work with distributors across the globe to make our product more accessible. At Anogen, we devote ourselves to produce high-quality and reliable antibody products for biomedical research, and hope that our contributions to the field can benefit patients, and improve the future of medicine.

CellCarta

CellCarta

Montréal, Canada

As a global leader in precision medicine testing services, we partner with our clients to address the most complex biomarker and bioanalytical challenges and deliver highly customized testing solutions. With facilities located in Canada, United States, Belgium, Australia and China, CellCarta provides the expertise needed locally to support global clinical trials. CellCarta offers access to integrated analytical platforms in immunology (immune monitoring), histopathology, proteomics and genomics, as well as digital pathology/AI and sample management, logistics and kitting services. At CellCarta we are experts at assessing the immune system, whether in the context of oncology, infectious diseases, or autoimmune diseases. With a proven track record in other therapeutic areas as, such as neurological and metabolic disorders, we handle all human biological specimens and deploy relevant technologies to extract valuable information for research and diagnostic applications. We provide assay development and testing services to support a wide variety of translational research, clinical trials, and diagnostic applications. Reflecting our commitment to quality, our sites hold the appropriate accreditations to support your regulatory requirements, including CAP, CLIA, ISO15189, ISO27001 and ISO13485.

Cytodiagnostics

Cytodiagnostics

919 Fraser Dr., Unit 11, Burlington, ON, L7L 4X8, Canada

Cytodiagnostics is a biotechnology and diagnostics company based in Burlington, ON, Canada, and Tulsa, OK, USA, and a Research and Development Position at the Innovate Calgary Life Science Hub at the University of Calgary. Over the past fifteen years, Cytodiagnostics has become the pre-eminent global supplier of gold and silver nanoparticles. With a commitment to providing quality materials, our in-depth knowledge of particle behaviour spans from initial synthesis to chemical functionalization and detection molecule conjugation, giving us a unique advantage for incorporating nanoparticles into diagnostic tests. This realization led to the creation of CytoGROUP, a branch of our business with the mission of using excellent materials to provide top-notch lab-based and point-of-care diagnostics. Our team has applied their expertise with chemical modifications as well as antibody and cutting-edge nucleic acid/aptamer detection molecules to create a range of products from lateral flow tests to plate-based assays, along with custom diagnostic test development services. In addition to our two locations, Cytodiagnostics also has an associate company, CytoGroup, which specializes in lateral flow and vertical flow assays, ELISA, ELASA and Aptamer Development. Both products and development services are available. Our goal is to serve our customers with the highest quality products to ensure success in their research and development efforts.

Gemina Laboratories Ltd.

Gemina Laboratories Ltd.

3800 Westbrook Mall Suite 142

We are Gemina Labs, a point-of-care test developer with a proprietary breakthrough chemistry platform. Founded in 2020, the Gemina chemistry platform is an advanced, “universal” bio-sensing toolkit that enables a new generation of diagnostic tests for infectious diseases and beyond. The chemistry platform isn’t just high-performing. It also overcomes many supply chain accuracy bottlenecks in the sector and cuts the development time for prototype tests to weeks. Best of all, the platform empowers “quantitative testing” (not just positive/negative tests) that opens up new applications in personal well-being (stress, fatigue monitoring etc.)

MedMira

MedMira

Halifax, Canada

MedMira is transforming rapid testing with our patented Rapid Vertical Flow Technology™, offering speed, accuracy and multiplexing. This technology enables targets of interest in a wide variety of sample types to be captured and visualized on a unique membrane. Rapid Vertical Flow Technology is a highly scalable solution that can be used in the development and commercialization of rapid testing applications across a broad range of life sciences and biotech sectors. It’s rapid testing reinvented.

Somru Bioscience

Somru Bioscience

Charlottetown, Prince Edward Island

Somru BioScience is an emerging biotechnology company dedicated to developing breakthrough antibody technology for research, diagnostic and therapeutic applications.